Search
for
Sort by
Research 181–210 of 1000+
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Inhibiting Janus kinases to treat alopecia areata
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- JAK inhibitors and alopecia areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia universalis. Partial response to tofacitinib
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- JAK Inhibitors for Treatment of Alopecia Areata
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Topical tofacitinib in treatment of alopecia areata
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Modern Management Approaches for Alopecia Areata
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development